21 hours Longboard Pharmaceuticals’ (LBPH) “Hold” Rating Reaffirmed at Truist FinancialMarketBeat
Truist Financial reiterated a “hold” rating and issued a $60.00 target price on shares of Longboard Pharmaceuticals in a research report on Tuesday.
Pharmaceuticals · Science · Truist Financial Corp (TFC)
X